Molly McElroy

Fred Hutch at ASH: Expanding CAR-T access, AML treatment strategies, climate and cancer — and ASH lifetime achievement award

Fred Hutch at #ASH25: Catch our latest findings in blood cancer treatments, efforts to improve access to innovative new therapies and the biological underpinnings of disease. 🩸👇 https://bit.ly/4iRN2BH

Congrats to the Cancer AI Alliance (CAIA) on being named @geekwire.com's Health Innovation of the Year! This Fred Hutch-led initiative unites experts to apply responsible #AI to cancer centers’ data, unlocking insights while ensuring data security. Learn more: www.canceralliance.ai

2025 GeekWire Awards

Our Cancer AI Alliance is up for Health Innovation of the Year for the Seattle-based Geekwire awards!

www.geekwire.com/events/2025-...

@fredhutch.bsky.social is very proud to represent our Alliance - we'd love your vote for the hard work being done by all of the people involved!

@science.org RNA polymerase II at histone genes predicts outcome in human cancer 🧬💊 @fredhutch.bsky.social @hhmi.bsky.social www.science.org/doi/10.1126/...

"The hope of using FMT with people receiving stem cell transplants is that FMT will help prevent acute GVHD without adding more immunosuppression, improve quality of life, and decrease mortality after transplant," explained Dr. Armin Rashidi.

7 Big Questions About Cancer, Answered Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this complex disease.

Much about how tumors metastasize still remains a mystery, said Fred Hutch's Dr. Kevin Cheung. His research recently showed that dead and dying cells within a tumor might create an environment that makes it easier for living tumor cells to get out and spread. www.nytimes.com/2025/01/29/w...

Four-component protein nanocages designed by programmed symmetry breaking - Nature Using viral capsid architectures as template for design, higher triangulation number nanocages that require symmetry breaking offer potential advances in targeted delivery and antigen-displaying vacci...

Could a tiny molecular soccer ball deliver vaccines and drugs to cells? The lab of UW's Dr. David Baker (2024 Nobel Prize Winner!), with Fred Hutch’s Barry Stoddard and Madison Kennedy, report the latest protein design results from their ongoing 25-year collaboration. www.nature.com/articles/s41...

Health and medicine publication STAT News lays off 11 employees - The Boston Globe The decision to lay off STAT employees comes after years of growth, including a significant expansion during the height of the COVID-19 pandemic.

Welp, the news is out. It's a gutting day for us at STAT with layoffs of 11 treasured, hardworking colleagues. I can't say this loud enough: Please subscribe/support the journalism you trust. Science writing jobs are going extinct at a time when we're needed most. www.bostonglobe.com/2024/12/09/b...

Sean J. Morrison, PhD, presents the E. Donnall Thomas Lecture at #ASH24. Named after Nobel laureate and founding Fred Hutch faculty member Dr. E. Donnall Thomas, this lecture recognizes paradigm-shifting discoveries in the field of #hematology.

Biopharma leaders lay out vision for the future of blood cancer treatment Biopharma leaders at companies developing blood cancer therapies say we shouldn’t be afraid to use the four-letter word: cure

Biopharma leaders lay out vision for the future of blood cancer treatment. Our second installment of @statnews.bsky.social's pop-up #ASH24 newsletter
www.statnews.com/2024/12/08/a...

Fred Hutch’s Dr. Mohamed Sorror presents the latest findings on a new health assessment model called CHARM, which helps health care teams predict which patients will survive transplantation. #ASH24 www.fredhutch.org/en/news/cent...

Fred Hutch at #ASH24: Hematologist-oncologist Dr. Natalie Wuliji presents findings from a multi-center study showing how socioeconomic status affects access to allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia #AML. ash.confex.com/ash/2024/web...

A lot of talent in this group! The Fred Hutch/UW Hematology-Oncology Fellows checking out our booth (3205) at #ASH24. Stop by to hear about the latest in the #PNW!

Speakers at #ASH24 press briefing, "Studies Highlight Progress in Preventing and Treating Blood Cancers and Pre-Cancerous Conditions" www.hematology.org/newsroom/pre...

At #ASH24: “The way we interpret it [is that] if patients are able to overcome the barriers to transplant … perhaps the outcomes could be comparable to patients from other socioeconomic backgrounds,” said Natalie Wuliji, the study’s lead author, hematologist-oncologist @fredhutch.bsky.social

At #ASH24, Dr. Natalie Wuliji, a hematologist-oncologist at @fredhutch.bsky.social, presents on social determinants of health and access to transplant for AML in an ASH press briefing: www.hematology.org/newsroom/pre...

Fred Hutch at #ASH24: Catch Dr. Filippo Milano's presentation: "CLAG-M or FLAG-Ida Followed Immediately By Allogeneic Hematopoietic Cell Transplantation for Adults with Relapsed/Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasm" 👉 bit.ly/41j6iky

Fred Hutch at ASH: Plenary session on socioeconomic barriers to transplant, new leukemia treatments and phasing out ‘cumbersome’ urine test The 66th Annual Meeting & Exposition of the American Society of Hematology (ASH) will take place in San Diego, Calif. and online Dec. 7-10. Improving access to life-saving therapies for blood disorder...

#ASH24 is kicking off in San Diego! See highlights of @fredhutch.bsky.social research to be presented, including socioeconomic barriers to transplant and clinical trial findings for blood cancers: www.fredhutch.org/en/news/rele...